Jen Banks, Ma, Ma, Pmp
About Jen Banks, Ma, Ma, Pmp
Jen Banks is a Director of Project Management specializing in FDA-regulated clinical trials and post-marketing surveillance. She has extensive experience in project management across various organizations, including WEP Clinical, Dana-Farber Cancer Institute, and PROMETRIKA, LLC.
Work at WEP Clinical
Currently, Jen Banks serves as the Director of Project Management at WEP Clinical, a position she has held since 2023. In this role, she specializes in overseeing project management for FDA-regulated clinical trials, specifically focusing on Phase 1 through 4 randomized controlled trials and post-marketing surveillance. Her responsibilities include managing various aspects of project execution, ensuring compliance with regulatory standards, and facilitating effective communication among stakeholders.
Education and Expertise
Jen Banks holds two Master's degrees, one in Management from Harvard University and another in Immunology from The Johns Hopkins University. She also earned a Bachelor of Science in Biochemistry from Tufts University. Her educational background supports her expertise in managing decentralized trials and social behavioral research within the clinical research industry. She emphasizes evidence-based decision-making and outcomes assessment in her project management practices.
Background
Jen Banks has extensive experience in project management within the clinical research field. Prior to her current role at WEP Clinical, she worked at various organizations, including PROMETRIKA, LLC, Sanguine, and Dana-Farber Cancer Institute. Her career spans over a decade, during which she has held positions ranging from Senior Project Manager to Program Manager, focusing on clinical research and project management in FDA-regulated environments.
Achievements
Throughout her career, Jen Banks has developed a comprehensive skill set in project management. She is proficient in managing scope, schedule, cost, quality, risk, resources, communications, stakeholders, vendors, and change control in projects. Her passion for process development and continuous improvement has contributed to her effectiveness in managing complex clinical trials and enhancing project outcomes.